Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.48 |
| ▸ | BLM | P54132 | 1/20 | 0.48 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.48 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.47 |
| ▸ | FNTA | P49354 | 4/20 | 0.46 |
| ▸ | FNTB | P49356 | 4/20 | 0.46 |
| ▸ | PGGT1B | P53609 | 3/20 | 0.46 |
| ▸ | DPP4 | P27487 | 1/20 | 0.44 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.44 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.44 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.44 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.44 |
| ▸ | SLC7A11 | Q9UPY5 | 1/20 | 0.44 |
| ▸ | CA2 | P00918 | 4/20 | 0.43 |
| ▸ | CA1 | P00915 | 3/20 | 0.43 |
| ▸ | ACE | P12821 | 1/20 | 0.42 |
| ▸ | RIMKLA | Q8IXN7 | 1/20 | 0.42 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.42 |
| ▸ | GSTK1 | Q9Y2Q3 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4227222 | 1.00 | KMT2A (0.48) | KMT2AALOX15BLMPMP22FOLH1 | |
| SCHEMBL7071336 | 0.95 | FOLH1 (0.47) | KMT2AALOX15BLMPMP22FOLH1 | |
| SCHEMBL7071333 | 0.95 | FOLH1 (0.47) | KMT2AALOX15BLMPMP22FOLH1 | |
| SCHEMBL30011195 | 0.92 | FOLH1 (0.47) | KMT2AALOX15BLMPMP22FOLH1 | |
| SCHEMBL30010559 | 0.92 | FOLH1 (0.47) | KMT2AALOX15BLMPMP22FOLH1 | |
| SCHEMBL30010906 | 0.92 | FOLH1 (0.47) | KMT2AALOX15BLMPMP22FOLH1 | |
| SCHEMBL30010917 | 0.92 | FOLH1 (0.47) | KMT2AALOX15BLMPMP22FOLH1 | |
| SCHEMBL29615273 | 0.91 | DPP4 (0.44) | KMT2AALOX15BLMPMP22FOLH1 | |
| SCHEMBL29615137 | 0.91 | DPP4 (0.44) | KMT2AALOX15BLMPMP22FOLH1 | |
| SCHEMBL6809858 | 0.89 | KMT2A (0.49) | KMT2AALOX15BLMPMP22FOLH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103623390-A | Glutamine for use in treating injury | UNIV COLORADO | 2014-03-12 | — | — | CN | claimed |
| EP-1663283-B1 | GLUTAMINE FOR USE IN TREATING INJURY | UNIV COLORADO (US) | 2012-05-23 | — | — | EP | claimed |
| EP-2106791-A1 | Glutamine or glutamine-containing dipeptide in a specific dosage for the treatment of inflammation | Biotempt B.V. (NL) | 2009-10-07 | — | — | EP | claimed |
| EP-1663283-A4 | GLUTAMINE FOR USE IN TREATING INJURY | UNIV COLORADO (US) | 2008-08-20 | — | — | EP | claimed |
| CN-1878564-A | Glutamine for the treatment of injury | UNIV COLORADO (US) | 2006-12-13 | — | — | CN | claimed |
| EP-1663283-A1 | GLUTAMINE FOR USE IN TREATING INJURY | University of Colorado (US) | 2006-06-07 | — | — | EP | claimed |
| WO-2005034980-A1 | GLUTAMINE FOR USE IN TREATING INJURY | UNIVERSITY OF COLORADO (US) | 2005-04-21 | — | — | WO | claimed |
| US-20050059610-A1 | Glutamine for use in treating injury | REGENTS OF THE UNIVERSITY OF COLORADO, THE | 2005-03-17 | — | — | US | claimed |
| EP-4684030-A2 | METHOD OF DEPROTECTING AT LEAST ONE D-AMINO ACID AND/OR D-AMINO ACID DERIVATIVE PROTECTED FUNCTIONAL GROUP | Martin-Luther-Universität Halle-Wittenberg (DE) | 2026-01-28 | — | — | EP | disclosed |
| US-20250074942-A1 | COMPOSITIONS AND METHODS FOR COVALENT PEPTIDE-BASED MODULATORS OF HLA-E | CALICO LIFE SCIENCES LLC (US) | 2025-03-06 | — | — | US | disclosed |
| WO-2024227957-A2 | METHOD OF DEPROTECTING AT LEAST ONE D-AMINO ACID AND/OR D-AMINO ACID DERIVATIVE PROTECTED FUNCTIONAL GROUP | Martin-Luther-Universität Halle-Wittenberg (DE) | 2024-11-07 | — | — | WO | disclosed |
| US-20240173375-A1 | CHEMOTACTIC AUTOPHAGY-INHIBITING PEPTIDE, COMPOSITIONS AND METHODS RELATED THERETO | BIOTEMPT B.V. (NL) | 2024-05-30 | — | — | US | disclosed |
| EP-4301391-A1 | CHEMOTACTIC AUTOPHAGY-INHIBITING PEPTIDE, COMPOSITIONS AND METHODS RELATED THERETO | Biotempt B.V. (NL) | 2024-01-10 | — | — | EP | disclosed |
| US-20230173089-A1 | Q-ER PEPTIDE | BIOTEMPT B.V. (NL) | 2023-06-08 | — | — | US | disclosed |
| EP-1663283-A1 | GLUTAMINE FOR USE IN TREATING INJURY | University of Colorado (US) | 2006-06-07 | — | — | EP | disclosed |
| WO-2005034980-A1 | GLUTAMINE FOR USE IN TREATING INJURY | UNIVERSITY OF COLORADO (US) | 2005-04-21 | — | — | WO | disclosed |
| US-20050059610-A1 | Glutamine for use in treating injury | REGENTS OF THE UNIVERSITY OF COLORADO, THE | 2005-03-17 | — | — | US | disclosed |
| EP-0571198-B1 | Cosmetic composition containing hair-growth promoter | UNILEVER PLC (GB) | 1997-03-19 | — | — | EP | disclosed |
| US-5559092-A | HAIR GROWTH, GLUTAMINE DIPEPTIDE | CHESEBROUGH-POND'S USA CO. DIVISION OF CONOPCO, INC. (US) | 1996-09-24 | — | — | US | disclosed |
| EP-0571198-A1 | Cosmetic composition containing hair-growth promoter | UNILEVER PLC (GB) | 1993-11-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250074942-A1 | COMPOSITIONS AND METHODS FOR COVALENT PEPTIDE-BASED MODULATORS OF HLA-E | MICA, CD74, HLA-DRB1 | KMT2A 357/4885ALOX15 3715/4885BLM 3938/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.